Advertisement

Optimizing Transient Recombinant Protein Expression in Mammalian Cells

  • Ralph F. Hopkins
  • Vanessa E. Wall
  • Dominic EspositoEmail author
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 801)

Abstract

Transient gene expression (TGE) in mammalian cells has become a routine process for expressing recombinant proteins in cell lines such as human embryonic kidney 293 and Chinese hamster ovary cells. The rapidly increasing need for recombinant proteins requires further improvements in TGE technology. While a great deal of focus has been directed toward optimizing the secretion of antibodies and other naturally secreted targets, much less work has been done on ways to improve cytoplasmic expression in mammalian cells. The benefits to protein production in mammalian cells, particularly for eukaryotic proteins, should be very significant – glycosylation and other posttranslational modifications will likely be native or near-native, solubility and protein folding would likely improve overexpression in heterologous hosts, and expression of proteins in their proper intracellular compartments is much more likely to occur. Improvements in this area have been slow, however, due to limited development of the cell culture processes needed for low-cost, higher-throughput expression in mammalian cells, and the relatively low diversity of DNA vectors for protein production in these systems. Here, we describe how the use of recombinational cloning, coupled with improvements in transfection protocols which increase speed and lower cost, can be combined to make mammalian cells much more amenable for routine recombinant protein expression.

Key words

Optimizing transient expression Gateway cloning Gateway Multisite HEK293E Polyethylenimine 

Notes

Acknowledgments

The authors thank Cammi Bittner, Veronica Roberts, Leslie Garvey, and Kelly Esposito for assistance in protocol development. This work has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government.

References

  1. 1.
    Peel, A., ed. Transfection of mammalian cells, in Methods, vol. 33, No 1, 2004.Google Scholar
  2. 2.
    Durocher, Y., Perret, S., and Kamen, A. (2002) High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells. Nucleic Acids Res. 30, 2–9.CrossRefGoogle Scholar
  3. 3.
    Boussif, O., Lezoualc’h, F., Zanta, M. A., Mergny, M. D., Scherman, D., Demeneix, B., and Behr, J.-P. (1995) A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine. Proc. Natl. Acad. Sci. 92, 7297–7301.PubMedCrossRefGoogle Scholar
  4. 4.
    Schlaeger, E.-J. and Christensen, K. (1999) Transient gene expression in mammalian cells grown in serum-free suspension culture. Cytotechnology 30, 71–83.PubMedCrossRefGoogle Scholar
  5. 5.
    Hartley, J.L., Temple, G.F., and Brasch, M.A. (2000) DNA cloning using in vitro site-specific recombination. Genome Res 10, 1788–95.PubMedCrossRefGoogle Scholar
  6. 6.
    Esposito, D., Garvey, L.A., and Chakiath C.S. (2009) Gateway cloning for protein expression. Methods Mol Biol 498, 31–54.PubMedCrossRefGoogle Scholar
  7. 7.
    Cheo, D.L., Titus, S.A., Byrd, D.R., Hartley, J.L., Temple G.F., and Brasch, M.A. (2004) Concerted assembly and cloning of multiple DNA segments using in vitro site-specific recombination: functional analysis of multi-segment expression clones. Genome Res 14, 2111–20.PubMedCrossRefGoogle Scholar
  8. 8.
    Sasaki Y, Sone T, Yoshida S, Yahata K, Hotta J, Chesnut JD, Honda T, Imamoto F. (2004) Evidence for high specificity and efficiency of multiple recombination signals in mixed DNA cloning by the Multisite Gateway system. J. Biotechnol. 107, 233–43.PubMedCrossRefGoogle Scholar
  9. 9.
    Sasaki, Y., Sone, T., Yahata K., Kishine H., Hotta, J., Chesnut, J.D., Honda, T., and Imamoto, F. (2008) Multi-gene gateway clone design for expression of multiple heterologous genes in living cells: eukaryotic clones containing two and three ORF multi-gene cassettes expressed from a single promoter. J. Biotechnol. 136, 103–12.PubMedCrossRefGoogle Scholar
  10. 10.
    Graham, F.L., Smiley, J., Russell, W.C., and Nairn, R. (1977). Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36, 59–74.PubMedCrossRefGoogle Scholar
  11. 11.
    Shaw, G., Morse, S., Ararat, M., and Graham, F.L. (2002) Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells. FASEB J. 16, 869–871.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Ralph F. Hopkins
    • 1
  • Vanessa E. Wall
    • 2
  • Dominic Esposito
    • 2
    Email author
  1. 1.Protein Expression LaboratorySAIC-Frederick, Inc.FrederickUSA
  2. 2.Protein Expression LaboratorySAIC-Frederick, Inc., National Cancer InstituteFrederickUSA

Personalised recommendations